BioMarin Pharmaceutical Inc
BMRN· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $191.79M | $136.81M | $124.02M | $110.63M |
| Net Income | -$33.50M | -$21.53M | -$32.01M | -$5.08M |
| EPS Diluted | -$0.23 |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.16 |
| -$0.27 |
| -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.